MADISON MCMILLAN: Open Payments
NPI 1255012126 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 38 payments from 12 companies in 2025. Trend: 2023 $73 · 2024 $748 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 10 | $293 |
| GENZYME CORPORATION | 9 | $167 |
| Inspire Medical Systems, Inc. | 1 | $115 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Smith+Nephew, Inc. | 1 | $55 |
| Philips North America LLC | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Genentech USA, Inc. | 1 | $28 |
Products named: Prolastin-C Liquid, DUPIXENT, INSPIRE, NUCALA, FASENRA, HALO, GLASSIA, Xolair.
Industry payments across KS — which companies pay providers there.
